APA (7th ed.) Citation

Ghazouani, L., Khdhiri, E., Elmufti, A., Zarei, A., Feriani, A., Baaziz, I., . . . Tlili, N. (2022). A novel synthetised sulphonylhydrazone coumarin (E)‐4‐methyl‐N′‐(1‐(3‐oxo‐3H‐benzo[f]chromen‐2‐ yl)ethylidene)benzenesulphonohydrazide protect against isoproterenol‐induced myocardial infarction in rats by attenuating oxidative damage, biological changes and electrocardiogram. Clinical and experimental pharmacology & physiology, 49(9), 1010-1026. https://doi.org/10.1111/1440-1681.13690

Chicago Style (17th ed.) Citation

Ghazouani, Lakhdar, et al. "A Novel Synthetised Sulphonylhydrazone Coumarin (E)‐4‐methyl‐N′‐(1‐(3‐oxo‐3H‐benzo[f]chromen‐2‐ Yl)ethylidene)benzenesulphonohydrazide Protect Against Isoproterenol‐induced Myocardial Infarction in Rats by Attenuating Oxidative Damage, Biological Changes and Electrocardiogram." Clinical and Experimental Pharmacology & Physiology 49, no. 9 (2022): 1010-1026. https://doi.org/10.1111/1440-1681.13690.

MLA (9th ed.) Citation

Ghazouani, Lakhdar, et al. "A Novel Synthetised Sulphonylhydrazone Coumarin (E)‐4‐methyl‐N′‐(1‐(3‐oxo‐3H‐benzo[f]chromen‐2‐ Yl)ethylidene)benzenesulphonohydrazide Protect Against Isoproterenol‐induced Myocardial Infarction in Rats by Attenuating Oxidative Damage, Biological Changes and Electrocardiogram." Clinical and Experimental Pharmacology & Physiology, vol. 49, no. 9, 2022, pp. 1010-1026, https://doi.org/10.1111/1440-1681.13690.